The precise relationship between viral infection and malignancy remains an epidemiologic association and the subject of active investigation. Nonmalignant hematologic disorders have a similarly complex relationship with cancer-associated viruses and may offer insight into the pathogenesis of oncogenesis. This book explores the relationships between viral infections, immune impairments and the hematologic and malignant diseases, particularly against the backdrop of the HIV epidemic. By extending the scope to all of viral oncology the editors provide an invaluable resource on tumors related to other viruses other than HIV, particularly carcinomas of the cervix and anus with HPV and tumors of the liver with the various hepatitis viruses.
These observations provoked investigators to restudy the role of immune surveillance against malignancy. At that time immune surveillance was thought to occur against tumor-specific antigens; thereby neoplasms were eliminated.
Virus precursors in the form of nucleic acids or antigens have consistently been associated with certain neoplasias. However, the role of these virus-specified precursors in etiology remains obscure.
The book also includes complementary clinically based chapters describing natural courses and treatments. Additionally, bonusclinical materials are embedded within chapters and an easy-to-use indexcompletes the book.
Organized into seven parts, this book begins with a discussion on the host-cell-virus relationships. Some chapters follow that discuss the comparative aspects of DNA and RNA oncogenic viruses.
There is an urgent need for vaccines against these types of cancer. This book describes various strategies to develop such vaccines.
The book concludes with chapters on herd immunity; viral immunopathology; and viral immunology and immunopathology. Immunologists, pathologists, virologists, and microbiologists will find the book useful.
However, at the molecular level most cancers are quite similar. Prostate cancer awareness and breast cancer awareness are the most publicized cancers, and funding support for these is greatest compared to other types.
The Role of Immunological Factors in Viral and Oncogenic Processes: Seventh International Symposium ... Baltimore, Maryland, May 31-June 1, 1973...
The Immunology of Malignant Disease
Titres of these antibodies were higher with increasing tumour load but lower in patients who survived a long while after the disease (3–29 years). The geographical distribution of Burkitt's tumour suggested that it might result from ...